Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.800
-0.010 (-0.55%)
At close: Dec 20, 2024, 4:00 PM
1.839
+0.039 (2.18%)
After-hours: Dec 20, 2024, 7:02 PM EST
Caribou Biosciences Stock Forecast
CRBU's stock price has decreased by -71.2% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Caribou Biosciences stock have an average target of 12, with a low estimate of 6.00 and a high estimate of 19. The average target predicts an increase of 566.67% from the current stock price of 1.80.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRBU stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $30 → $6 | Strong Buy | Maintains | $30 → $6 | +233.33% | Nov 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +400.00% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +400.00% | Sep 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +400.00% | Aug 14, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $14 | Buy | Reiterates | $14 | +677.78% | Aug 7, 2024 |
Financial Forecast
Revenue This Year
10.47M
from 34.48M
Decreased by -69.64%
Revenue Next Year
10.34M
from 10.47M
Decreased by -1.18%
EPS This Year
-1.69
from -1.38
EPS Next Year
-1.91
from -1.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 12.6M | 14.7M | 105.0M | |||
| Avg | 10.5M | 10.3M | 28.7M | |||
| Low | 7.7M | n/a | 9.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -63.5% | 40.4% | 915.1% | |||
| Avg | -69.6% | -1.2% | 177.8% | |||
| Low | -77.5% | - | -5.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.55 | -1.38 | -1.76 | |||
| Avg | -1.69 | -1.91 | -2.10 | |||
| Low | -1.71 | -2.85 | -2.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.